Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
21.48
+0.36 (1.70%)
Nov 16, 2026, 3:20 PM EST - Market open

Assembly Biosciences Revenue

Assembly Biosciences had revenue of $2.96M in the quarter ending September 30, 2026, a decrease of -72.60%. This brings the company's total for the last twelve months to $67.01M, up 80.18% year-over-year. In the year 2025, Assembly Biosciences had annual revenue of $72.30M with 153.52% growth. That makes Assembly Biosciences the 25,809th largest company in the world by revenue and 3,567th in the United States.

Revenue (ttm)
$67.01M
Revenue Growth
+80.18%
P/S Ratio
6.64
Revenue / Employee
$917,973
Employees
73
Market Cap
439.85M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202572.30M43.78M153.52%
Dec 31, 202428.52M21.36M298.16%
Dec 31, 20237.16M--
Dec 31, 2022---
Dec 31, 20216.25M-72.85M-92.09%
Dec 31, 202079.11M63.14M395.55%
Dec 31, 201915.96M1.16M7.83%
Dec 31, 201814.80M5.79M64.14%
Dec 31, 20179.02M--
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.